Table 1.
Characteristics | n (%) |
---|---|
Sex | |
Male | 40 (46.0) |
Female | 47 (54.0) |
Age | |
≤ 50 years | 42 (48.3) |
> 50 years | 45 (51.7) |
Mean ± standard deviation | 51.5 ± 14.8 |
Primary site | |
Parotid gland | 27 (31.0) |
Submandibular gland | 15 (17.2) |
Palate | 19 (21.8) |
Tongue | 5 (5.7) |
Nasal cavity/paranasal sinus/nasopharynx | 10 (11.4) |
Lacrimal gland | 4 (4.6) |
Other sites | 7 (8.0) |
Tumor size (T) | |
T1 | 23 (26.4) |
T2 | 21 (24.1) |
T3 | 14 (16.1) |
T4 | 29 (33.3) |
Lymph node metastasis (N) | |
N0 | 75 (86.2) |
N1 | 7 (8.0) |
N2 | 3 (3.4) |
N3 | 2 (2.3) |
Distant metastasis (M) | |
M0 | 73 (83.9) |
M1 | 14 (16.1) |
TNM stage | |
I | 21 (24.1) |
II | 17 (19.5) |
III | 10 (11.5) |
IV | 39 (44.8) |
Histopathological pattern | |
Tubular | 31 (35.6) |
Cribriform | 36 (41.4) |
Solid | 20 (23.0) |
Perineural invasion | |
Absent | 33 (37.9) |
Present | 54 (62.1) |
Surgical margins | |
Negative | 50 (57.5) |
Positive | 37 (42.5) |
Treatment | |
Surgery | 16 (18.4) |
Surgery + RT | 38 (43.7) |
Surgery + ChT | 2 (2.3) |
Surgery + RT + ChT | 26 (29.9) |
RT + ChT | 4 (4.6) |
ChT | 1 (1.1) |
Recurrence | |
No | 57 (65.5) |
Yes | 30 (34.5) |
Survival statusa | |
Remission | 40 (49.4) |
Disease in progression | 12 (14.8) |
Death caused by tumor | 29 (35.8) |
Total | 87 (100.0) |
TNM tumor-node-metastasis, RT radiotherapy, ChT chemotherapy
aSix cases had no information regarding survival status